Industry News
Mystery disease identified and potential cure found
An international research team has identified the mysterious disease afflicting families in Belgium, England and France for the past several decades — as well as a potential cure. [ + ]
Malaria from the age of the dinosaurs?
A researcher from Oregon State University has claimed that malaria evolved in insects at least 100 million years ago. His research suggests that the first vertebrate hosts of this disease were probably reptiles, which at that time would have included the dinosaurs. [ + ]
Plans for Phase 3 smoking cessation trial underway
Invion has met with the US FDA to discuss Phase 3 plans for development of oral INV102 (nadolol) as a treatment for patients with chronic obstructive pulmonary disease (COPD) who cannot quit cigarette smoking. [ + ]
Get GHS ready at a forum near you
Comcare is holding a series of Australia-wide forums focusing on the transition to the new international system of chemical labelling and classification. [ + ]
Repairing blood vessels to improve anticancer treatment
A new drug could be used to repair the blood vessel defects that prevent current anticancer treatments from entering tumours. [ + ]
Australia has a diverse STEM workforce — but still lacking in women
The Office of the Chief Scientist has released a detailed analysis of Australia's science, technology, engineering and mathematics (STEM) trained workforce. [ + ]
MoU to strengthen biomedical science partnership
The Australian Institute of Medical Scientists and the UK Institute of Biomedical Science have signed a memorandum of understanding that is intended to strengthen the partnership between the two organisations. [ + ]
FameLab's NSW semifinalists live on stage
Semifinalists in the science communication competition FameLab will take to the stage on 7 April at the Powerhouse Museum, Sydney. [ + ]
Research Engagement and Impact working groups appointed
The Australian Research Council has announced the members of the two Engagement and Impact working groups that will assist in the development of a research engagement and impact assessment for Australia. [ + ]
IDT's new manufacturing partner
WellSpring Pharma Services has agreed to manufacture two to three pharmaceutical products that require manufacturing processes or scale not currently available at IDT's Boronia facilities. [ + ]
Wet AMD trial completes patient enrolment
Opthea has completed patient enrolment in its ongoing phase 1 dose escalation clinical trial of OPT-302 as a novel therapy for wet age-related macular degeneration (wet AMD). [ + ]
Testing reproductive compatibility with fluorescent sperm
Scientists from The University of Western Australia have used fluorescent green dye to observe different sperm competing to fertilise eggs. [ + ]
Accelerating anticancer drug discovery
MecRx has secured a $4 million investment from the Medical Research Commercialisation Fund to advance its breakthrough technology for accelerating drug discovery. [ + ]
How to improve benchtop particle accelerators
Researchers have proposed a way to improve the beam quality of laser wakefield accelerators, also known as benchtop accelerators. [ + ]
Prostate Cancer Foundation opens 2016 funding round
The Prostate Cancer Foundation of Australia has opened its annual funding round with the aim of supporting groundbreaking prostate cancer research. [ + ]
